Top Gene Therapy for Hemophilia companies

Key players in Gene Therapy for Hemophilia

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Gene Therapy for Hemophilia market

#	Company	Website	Our reports
1	BBioMarin	—	165 reports
2	CCSL Behring	—	231 reports
3	Pfizer Inc.	pfizer.com (opens in a new tab)	2,310 reports
4	Roche	roche.com (opens in a new tab)	1,485 reports
5	SSangamo Therapeutics	—	33 reports

Top trial sponsors in Gene Therapy for Hemophilia

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

1. Pfizer Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
2. Shanghai Xinzhi BioMed Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Gene Therapy for Hemophilia reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Gene Therapy for Hemophilia, with active trials